findmyKOL
Clinical trialNCT05546047UnknownPhase 4Interventional

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

SponsorNephroNet, Inc.Enrollment34Fibrillary Glomerulonephritis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Multicenter, Comparative Safety and Efficacy Study of Acthar gel alone or in combination with oral Tacrolimus to reduce urinary proteinuria in patients with idiopathic DNAJB9 Positive Fibrillary glomerulopathy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford University

    Stanford, California, United States

  • University of Colorado Anschutz Medical Department of Medicine Division of Renal Diseases and Hypertension

    Aurora, Colorado, United States

  • Georgia Nephrology Dba Georgia Nephrology Research Institute

    Lawrenceville, Georgia, United States

  • Columbia University Research Dept of Nephrology

    New York, New York, United States

  • Northeast Clinical Research Center

    Bethlehem, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Acthar Gel 80 UNT/ML Injectable Solution
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Mar 2019
Primary completion
27 Oct 2023
Completion
27 Oct 2024
Last update posted
31 Oct 2022
Registered enrollment
34
Registry id
NCT05546047
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.